RT-PCR Market Size, Share, and Growth Analysis by 2031

The RT-PCR market size is projected to reach US$ 2.71 billion by 2031 from US$ 4.47 billion in 2024. The market is expected to register a CAGR of 7.5% during 2025–2031.

RT-PCR Market Analysis

RT-PCR is a widely preferred test in molecular diagnostics due to its high sensitivity and specificity. Despite reductions in COVID-19 mass testing, demand for RT-PCR continues to grow due to infectious disease surveillance, oncology, genetic testing, and respiratory viral multiplex panels.

Advanced testing features, including automation, shorter turnaround times, and integration with other syndromic testing platforms, enhance RT-PCR efficiency and accelerate speed to market. The growing availability of RT-PCR systems in emerging markets and ongoing global pathogen circulation are driving the need for a robust worldwide RT-PCR infrastructure.

RT-PCR Market Overview  

RT-PCR enables rapid and sensitive detection of pathogens, genetic mutations, and gene expression.  RT-PCR is primarily used for infectious disease testing, such as detecting respiratory viruses and HIV, as well as for oncology and biomarker profiling. It is also applied in genetic screening and research.

Major companies in this space are Thermo Fisher Scientific, Roche, Bio-Rad, QIAGEN, and Abbott. They provide product offerings including instruments, reagents, and kits. Innovative advancements include multiplex assays, digital PCR integration, and point-of-care systems to generate quicker results. North America leads the market due to strong research and development activity and support from regulatory agencies. Europe and Asia Pacific have been witnessing an increase in the prevalence of chronic and infectious diseases and are gradually catching up to North America. Current market trends include automation, artificial intelligence-enhanced analysis, and portable devices for decentralized testing.     

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

RT-PCR Market: Strategic Insights

RT-PCR Market Drivers and Opportunities

Market Drivers:

• Infectious disease surveillance: Continuous circulation of respiratory, emerging, and endemic pathogens sustains demand for accurate, multiplex RT-PCR testing.
• Technological advancements: Automation, high-throughput platforms, and faster turnaround times improve laboratory efficiency, scalability, and adoption across clinical and public health settings.

Market Opportunities:

• Multiplex respiratory testing expansion: Growing need to simultaneously detect influenza, RSV, SARS-CoV-2, and emerging pathogens creates sustained demand for advanced RT-PCR panels.
• Emerging Markets Expansion: Expansion of near-patient testing in clinics and resource-limited settings opens new markets for compact, automated RT-PCR platforms.

RT-PCR Market Report Segmentation Analysis

The RT-PCR market is divided into different segments to give a clearer view of how it works, its growth potential, and the latest trends. Below is the standard segmentation approach used in industry reports:

By Product:

• Reagents & Consumables: The reagents and consumables segment is growing due to repeated purchases of RT-PCR kits and enzymes driven by ongoing illnesses and continuous monitoring needs.
• Instruments:  The instruments segment is growing due to increased laboratory automation, replacement of older laboratory systems, and rising demand for molecular diagnostics in clinical, research, and public health laboratories.
• Software & Services: The growth of the software and services segment is driven by rising demand for RT-PCR result analysis and automation, along with service support and seamless integration with laboratory information systems. 

By Application:

• Research Application: The research application segment is driven by the increased use of RT-PCR in genomics, gene expression studies, biomarker discovery, and academic and pharmaceutical research advancements.
• Clinical Application: The clinical application segment is growing due to rising demand for accurate molecular diagnostics in infectious diseases, oncology, genetic testing, and routine hospital laboratory testing worldwide. The clinical application segment is further sub-segmented into oncology testing, blood screening, infectious disease testing, and other applications.
• Forensic Application: The forensic application segment is growing due to the increasing use of RT-PCR in DNA analysis, crime investigation, human identification, and sensitive detection of biological evidence.

By End User:

• Hospitals and Diagnostic Centers
• Pharmaceutical and Biotechnology Companies
• Research Laboratories and Academic Institutes
• Forensic Laboratories
• Clinical Research Organizations

By Geography:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

The regional trends and factors influencing the RT-PCR Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses RT-PCR Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

RT-PCR Market Report Scope

RT-PCR Market Players Density: Understanding Its Impact on Business Dynamics

The RT-PCR Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

RT-PCR Market Share Analysis by Geography

North America leads the global RT-PCR market due to advanced healthcare infrastructure, high research investment, strong diagnostic testing demand, and the presence of major biotech and diagnostic companies driving adoption across clinical and research applications.

Europe follows as a major regional contributor, supported by well-established healthcare systems, proactive genetic and infectious disease testing initiatives, and extensive use of RT-PCR in clinical and research settings.  

The market in Asia Pacific is growing at the fastest rate, propelled by expanding healthcare access, rising demand for molecular diagnostics, government health investments, and increasing laboratory capacity in countries such as China, India, and Japan.  

Latin America and Middle East & Africa represent emerging markets with growing demand as public health surveillance and diagnostic infrastructure improve. However, their current scale remains smaller compared with North America, Europe, and Asia Pacific.

Below is a summary of market share and trends by region:

1. North America

• Market Share: Holds a significant portion of the global market
• Key Drivers:
  • Rising prevalence of cancer and demand for precision oncology diagnostics  
  • Persistent infectious disease threats and surveillance needs
•  Trends: Shift toward digital PCR and multiplex assays for enhanced sensitivity

2. Europe

• Market Share: Holds a substantial market share
• Key Drivers:
  • Escalating cancer incidence is fueling demand for molecular oncology diagnostics
  • Persistent antimicrobial resistance and respiratory infections are driving surveillance needs  
• Trends: Adoption of digital PCR and multiplex assays for enhanced precision.

3. Asia Pacific

• Market Share: Fastest-growing region with a steadily increasing market share each year.
• Key Drivers:
  • Rapidly rising cancer incidence is driving molecular oncology diagnostics  
  • Endemic infectious diseases and outbreak preparedness are driving increased surveillance.
• Trends: Adoption of digital PCR and multiplex assays for high-throughput applications.

4. South and Central America

• Market Share: Growing market with steady progress
• Key Drivers:
  • High infectious disease burden  
  • Investment in healthcare infrastructure and diagnostics  
• Trends: Shift toward decentralized and rapid testing

5. Middle East and Africa

• Market Share: Holds a small market share, growing at a rapid pace
• Key Drivers:
  • Rising infectious and genetic disease burden  
  • Substantial investments in healthcare infrastructure
• Trends: Shift toward decentralized and point-of-care testing.

RT-PCR Market Players Density: Understanding Its Impact on Business Dynamics

High Market Density and Competition

Competition is strong due to the presence of established players such as Abbott Laboratories and Takara Bio Inc. Niche providers also contribute to the competitive landscape across regions.

This high level of competition urges companies to stand out by offering:

• Advanced Products
• Value-added services such as customization and sustainable solutions
• Competitive pricing models
• Compliance with regulatory guidelines

Opportunities and Strategic Moves

• Bio-Rad launched its CFX Opus Deepwell Dx real-time PCR system, an open platform for developing in vitro diagnostic assays. The system multiplexes up to five targets and allows reaction volumes up to 125 µL in a 96-well format for quantitative PCR diagnostic assays. CFX Maestro Dx SE software provides data management and analysis tools.
• Roche launched a next-generation qPCR system to advance clinical needs in molecular diagnostics and address public health challenges.

Major Companies operating in the RT-PCR Market are:

1. Abbott
2. Qiagen
3. Bio-Rad Laboratories Inc.
4. Agilent Technologies, Inc.
5. Thermo Fisher Scientific, Inc.
6. GE Healthcare
7. bioMérieux
8. F. Hoffmann-La Roche Ltd
9. Takara Bio Inc
10.  Genome Diagnostics Pvt Ltd

Disclaimer: The companies listed above are not ranked in any particular order.

Other companies analyzed during the course of research:

1. Danaher Corporation (Cepheid)
2. PerkinElmer, Inc.
3. Promega Corporation
4. Seegene Inc.
5. Eurofins Scientific
6. Meridian Bioscience, Inc.
7. Microsynth AG
8. Altona Diagnostics GmbH
9. Bio-Techne Corporation
10. Luminex Corporation
11. Wikipedia
12. Analytik Jena AG
13. Bioneer Corporation
14. Hologic Inc.
15. Becton Dickinson & Company (BD)
16. DiaSorin S.p.A.
17. BGI Genomics Co., Ltd.
18. Sysmex Inostics GmbH
19. QuantuMDx Group
20. Co-Diagnostics (CoDx)
21. GeneDireX, Inc

RT-PCR Market News and Recent Developments

• Takara Bio launches a high-throughput, cost-effective qPCR system to advance clinical research in November 2024.: Takara Bio USA, Inc. announced the launch of the SmartChip ND Real-Time PCR System, an automated, research-use-only, high-throughput qPCR solution for infectious disease research. Takara Bio USA is now accepting orders of the SmartChip ND Real-Time PCR System.
• BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec in December 2025.: BD announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics offerings in Europe following In Vitro Diagnostic Medical Device Regulation (IVDR) certification of two VIASURE assays developed by Certest Biotec for use on the BD MAX™ System. The addition of these new assays to the BD MAX™ System portfolio enables clinical laboratories to detect a broad range of pathogens quickly and accurately using a fully automated molecular platform.      

RT-PCR Market Report Coverage and Deliverables

The "RT-PCR Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

• RT-PCR Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• RT-PCR Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST and SWOT analysis
• RT-PCR Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the RT-PCR Market
• Detailed company profiles